血液分離術市場規模、佔有率和成長分析（按產品、流程、技術、應用、最終用戶和地區分類）—2026-2033年產業預測

預計到 2024 年，血液分離術市場規模將達到 34.5 億美元，到 2025 年將達到 38.3 億美元，到 2033 年將達到 89.2 億美元，在預測期（2026-2033 年）內，複合年成長率為 11.15%。

受多種疾病發病率上升和對安全血液成分需求成長的推動，血液分離術市場持續穩定擴張。技術進步催生了創新血液分離術，並提高了手術效率。支持性的報銷政策和血液分離療法的資金支持進一步推動了市場發展。此療法已逐漸成為血栓性血小板低下紫斑症、溶血性尿毒症候群和自體免疫疾病等疾病的第一線和輔助治療手段。新產品的不斷推出顯著影響市場成長前景。然而，訓練有素的專業人員短缺、血液安全問題以及高昂的手術費用等挑戰仍需解決，以維持市場成長動能。整體而言，血液分離術在臨床應用中展現出巨大的潛力。

血液分離術市場促進因素

慢性疾病（包括癌症、自體免疫疾病和心血管疾病）的日益普遍，顯著推動了血液分離術的需求。血液分離術能夠選擇性地去除或收集特定的血液成分，對於有效管理這些健康問題至關重要。這種標靶治療方法能夠改善患者照護和治療效果，使其成為對抗嚴重患者治療方案中的關鍵組成部分。隨著醫療專業人員尋求創新解決方案來應對複雜的醫療挑戰，對個人化醫療和改善醫療保健管理策略的持續重視，進一步推動了血液分離術市場的成長。

血液分離術市場限制

由於設備和治療流程高成本，血液分離術市場面臨嚴峻挑戰。購買和維護這些專業設備所需的大量資金投入，可能會阻礙醫療機構的廣泛採用。此外，血液分離機的安裝和操作也較為複雜，會阻礙市場擴張。雪上加霜的是，潛在捐血者對捐血分離術技術的認知度較低，這會導致參與率低，最終限制市場成長潛力。因此，這些因素共同限制了血液分離術產業的發展。

血液分離術市場趨勢

血液分離術領域的關鍵市場趨勢是個人化醫療和標靶治療的日益普及。隨著醫療技術的進步，人們越來越重視根據患者的個別特徵（例如疾病狀態、基因標記和治療反應）來客製化治療方案。這種個人化方法不僅能提高治療效果，還能最佳化患者預後，進而提升醫療品質。此外，先進數據分析和生物標記識別技術的整合有望推動血液分離術技術的創新，並帶動對能夠針對各種疾病狀態進行個人化治療性介入的解決方案的需求。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析及其影響

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 監管環境
• 關鍵投資機會
• 市場吸引力指數
• 技術進步
• 市場生態系統
• 專利分析
• 價值鏈分析
• 案例研究分析
• 總體經濟指標

全球血液分離市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 血液分離耗材
  • 離心式血液分離裝置
  • 膜分離設備
• 血液分離機

全球血液分離術市場規模（按手術類型和複合年成長率分類）（2026-2033 年）

• 血漿置換療法
• 血小板分離方法
• 紅血球分離療法
• 白血球分離法
• 光療
• 低密度脂蛋白血漿置換術
• 其他

全球血液分離術市場規模（依技術及複合年成長率分類）（2026-2033 年）

• 離心
  • 連續流離失所
  • 間歇流離心
• 膜分離

全球血液分離術市場規模（按應用領域分類）及複合年成長率（2026-2033 年）

• 腎臟疾病
• 神經病學
• 血液學
• 癌症
• 自體免疫疾病
• 心血管疾病
• 其他

全球血液分離術市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 血液採集中心和血液成分供應商
• 醫院及輸血中心
• 其他

全球血液分離術市場規模（按地區分類）及複合年成長率（2026-2033 年）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Terumo BCT, Inc.（Japan）
• Fresenius Medical Care（Germany）
• Haemonetics Corporation（United States）
• Baxter International（United States）
• Asahi Kasei Medical Co., Ltd.（Japan）
• Kaneka Corporation（Japan）
• Cerus Corporation（United States）
• B. Braun Melsungen AG（Germany）
• Macopharma SA（France）
• Kawasumi Laboratories（Japan）
• Nikkiso Co., Ltd（Japan）
• Medica SPA（Italy）
• Miltenyi Biotec（Germany）
• Otsuka Holdings（JIMRO）（Japan）
• Cytosorbents Corporation（United States）
• Bioelettronica Srl（Italy）
• Guangzhou Daji Medical（China）
• Beijing ZKSK Technology（China）
• Infomed SA（Switzerland）
• Haier Biomedical（China）

結論與建議

Apheresis Market size was valued at USD 3.45 Billion in 2024 and is poised to grow from USD 3.83 Billion in 2025 to USD 8.92 Billion by 2033, growing at a CAGR of 11.15% during the forecast period (2026-2033).

The apheresis market is witnessing robust expansion, fueled by an increasing incidence of various diseases and a growing need for safe blood components. Advances in technology are leading to the development of innovative apheresis techniques, enhancing procedural effectiveness. Supportive reimbursement policies and funding for apheresis treatments further bolster market dynamics. This therapy is gaining traction as both a primary and adjunct treatment for conditions such as thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, and autoimmune diseases. The continual introduction of new products significantly influences growth prospects. Nonetheless, challenges such as a shortage of trained professionals, concerns regarding blood safety, and high procedural costs need to be addressed to maintain the momentum of market growth. Overall, apheresis demonstrates promising potential in clinical applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Apheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Apheresis Market Segments Analysis

Global Apheresis Market is segmented by product, procedure, technology, application, end user and region. Based on Product, the market is segmented into Apheresis Disposals and Apheresis Devices. Based on Procedure, the market is segmented into Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, Photopheresis, LDL-apheresis, and Others. Based on technology, the market is segmented into Centrifugation, and Membrane Separation. Based on application, the market is segmented into Renal Diseases, Neurology, Haematology, Cancer, Autoimmune Diseases, Cardiovascular Diseases and others. Based on end user, the market is segmented into Blood Collection Centers & Blood Component Providers, Hospitals & Transfusion Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Apheresis Market

The increasing prevalence of chronic conditions, including cancer, autoimmune diseases, and cardiovascular disorders, significantly boosts the demand for apheresis procedures. Apheresis is essential for effectively managing these health issues, as it allows for the selective removal or collection of particular blood components. This targeted approach enhances patient care and treatment outcomes, making apheresis a vital component in the therapeutic landscape for individuals battling these serious illnesses. The ongoing emphasis on personalized medicine and improved health management strategies further supports the growth of the apheresis market, as healthcare providers seek innovative solutions to address complex medical challenges.

Restraints in the Apheresis Market

The apheresis market faces significant challenges due to the high costs linked to both the devices and the therapeutic procedures. The substantial financial investment needed for acquiring and maintaining these specialized devices can deter healthcare facilities from adopting them widely. Moreover, the complexities involved in the installation and operation of apheresis equipment may also impede market expansion. Compounding these issues is the limited awareness of apheresis techniques among potential blood donors, which can lead to a decline in participation, ultimately restricting the growth potential of the market. Thus, these factors collectively present considerable restraints on apheresis industry development.

Market Trends of the Apheresis Market

A significant market trend in the apheresis sector is the rising acceptance of personalized medicine and targeted therapies. As healthcare technology advances, there is an increasing focus on customizing treatments to align with individual patient needs, including their unique medical conditions, genetic markers, and responses to treatments. This personalized approach not only enhances therapeutic efficacy but also optimizes patient outcomes, resulting in improved care quality. Furthermore, the integration of advanced data analytics and biomarker identification is likely to propel innovation in apheresis technologies, driving demand for solutions that facilitate tailored therapeutic interventions across various medical conditions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Regulatory Landscape
• Top Investment Pockets
• Market Attractiveness Index
• Technology Advancement
• Market Ecosystem
• Patent Analysis
• Value Chain Analysis
• Case Study Analysis
• Macro-Economic Indicators

Global Apheresis Market Size by Product & CAGR (2026-2033)

• Market Overview
• Apheresis Disposals
  • Centrifugal Apheresis Devices
  • Membrane Separators
• Apheresis Devices

Global Apheresis Market Size by Procedure & CAGR (2026-2033)

• Market Overview
• Plasmapheresis
• Plateletpheresis
• Erythrocytapheresis
• Leukapheresis
• Photopheresis
• LDL-apheresis
• Others

Global Apheresis Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Centrifugation
  • Continuous Flow Centrifugal
  • Intermittent Flow Centrifugation
• Membrane Separation

Global Apheresis Market Size by Application & CAGR (2026-2033)

• Market Overview
• Renal Diseases
• Neurology
• Haematology
• Cancer
• Autoimmune Diseases
• Cardiovascular Diseases
• Others

Global Apheresis Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Blood Collection Centers & Blood Component Providers
• Hospitals & Transfusion Centers
• Others

Global Apheresis Market Size & CAGR (2026-2033)

• North America (Product, Procedure, Technology, Application, End-User)
  • US
  • Canada
• Europe (Product, Procedure, Technology, Application, End-User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Product, Procedure, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Product, Procedure, Technology, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Procedure, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Terumo BCT, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Medical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerus Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kawasumi Laboratories (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica SPA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Holdings (JIMRO) (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytosorbents Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioelettronica S.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guangzhou Daji Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing ZKSK Technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infomed SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haier Biomedical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation